AORTIC RESTENOSIS

This adverse event was reported 6 times

These drugs are most commonly taken by patients reporting AORTIC RESTENOSIS:

# Drug Count
0 ADALIMUMAB 1
1 DULAGLUTIDE 1
2 METFORMIN 1
3 METFORMIN ER 500 MG 1
4 METFORMIN ER 750 MG 1
5 SOFOSBUVIR 1
6 TAFAMIDIS MEGLUMINE 1
See all common drugs associated with AORTIC RESTENOSIS

AORTIC RESTENOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TAFAMIDIS MEGLUMINE 1 0.0002
1 SOFOSBUVIR 1 0.0001
2 DULAGLUTIDE 1 0.0000
3 METFORMIN ER 500 MG 1 0.0000
4 ADALIMUMAB 1 0.0000
See all drugs enriched for association with AORTIC RESTENOSIS

These drug classes are most commonly taken by patients reporting AORTIC RESTENOSIS:

# Drug class Count
0 GLP-1 Receptor Agonist [EPC] 1
1 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1
See all common drug classes associated with AORTIC RESTENOSIS

AORTIC RESTENOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
1 GLP-1 Receptor Agonist [EPC] 1 0.0000
See all drug classes enriched for association with AORTIC RESTENOSIS